Correction: miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6 (PLoS ONE (2014) 9:7 (e101530) DOI: 10.1371/journal.pone.0101530);miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Jiang, Weiwei ^a   Kong, Liangliang ^b   Ni, Qingfeng ^b   Lu, Yeting ^b   Ding, Wenzhou ^b   Liu, Guoqing ^a   Pu, Liyong ^b   Tang, Weibing ^a   Kong, Lianbao ^b  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MICRORNA 146A; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, MOUSE; MICRORNA; MIRN146 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPOXIA; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; IMMUNOLOGY; INFLAMMATION; LIVER; LIVER FAILURE; MACROPHAGE; METABOLISM; PATHOLOGY;

ANIMALS; CELL HYPOXIA; CELL LINE; DOWN-REGULATION; HEPATIC INSUFFICIENCY; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIVER; MACROPHAGES; MALE; MICE, INBRED C57BL; MICRORNAS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTORS;

EID: 84903778202     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0288672     Document Type: Erratum

References (43)

1. Theodoraki K, Arkadopoulos N, Nastos C, Vassiliou I, Karmaniolou I, et al. (2012) Small liver remnants are more vulnerable to ischemia/reperfusion injury after extended hepatectomies: a case-control study. World J Surg 36, 2895-2900.
2. Wu J, Tang Q, Shen J, Yao A, Wang F, et al. (2010) Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5. J Hepatol 53, 73-83.
3. Onoe T, Tanaka Y, Ide K, Ishiyama K, Oshita A, et al. (2013) Attenuation of Portal Hypertensio- n by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Don- or Liver Transplantation. Transplantation 95, 1521-1527.
4. Yang ZF, Ho DW, Chu AC, Wang YQ, Fan ST (2004) Linking inflammation to acute rejection in small-for-size liver allografts: the potential role of early macrophage activation. Am J Transplant 4, 196-209. (Pubitemid 38248522)
5. Liang TB, Man K, Lee TKW, Tsui SHT, Lo CM, et al. (2003) Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation 75, 673-678. (Pubitemid 36337367)
6. Klune JR, Tsung A (2010) Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am 90, 665-677.
7. Ellett JD, Evans ZP, Atkinson C, Schmidt MG, Schnellmann RG, et al. (2009) Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury. Liver Transpl 15, 1101-1109.
8. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16, 329.
9. Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322-335. (Pubitemid 351975556)
10. Chassin C, Hempel C, Stockinger S, Dupont A, Kubler JF, et al. (2012) MicroRNA-146a- mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol Med 4, 1308-1319.
11. Yuan P, Liu Z, Liu M, Huang J, Li X, et al (2013) Up-regulated tumor necrosis factor-associat- ed factor 6 level is correlated with apoptosis in the rat cerebral ischemia and reperfusion.Neurol Sci 34, 1133-1138.
12. Ambros V (2004) The functions of animal microRNAs. Nature 431, 350-5.
13. Konstantin DT, Mark PB, Kuang-Jung C, David B (2006) NF-κB- dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. PNAS 103, 12481-12486.
14. Chen Q, Kong LB, Xu X, Geng Q, Tang W, et al. (2013) Down-Regulation of MicroRNA-146a in the Early Stage of Liver Ischemia-Reperfusion Injury. Transplantation proceedings 45, 492-496.
15. Jiang W, Tang W, Geng Q, Xu X (2011) Inhibition of Toll-like receptor 4 with vasoactive intestinal peptide attenuates liver ischemia-reperfusion injury. Transplantation proceedings 43, 1462-1467.
16. Tukov FF, Maddox JF, Amacher DE, Bobrowski WF, Roth RA, et al (2006) Modeling inflammation-drug interactions in vitro: A rat Kupffer cell-hepatocyte coculture system. Toxicology in vitro 20, 1488-1499. (Pubitemid 44537656)
17. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 22 DDCt Method. Methods 25, 402-408. (Pubitemid 34164012)
18. Ke B, Shen XD, Ji H, Kamo N, Gao F, et al. (2012) HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: Regulation of TLR4 innate responses through PI3K/PTEN signaling. Journal of hepatology 56, 359-366.
19. Ma Y, Ma L, Guo Q, Zhang S (2010) Research Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. Journal of Experimental & Clinical Cancer Research 29, 85.
20. Wang X, Guo B, Li Q, Peng J, Yang Z, et al. (2013) miR-214 targets ATF4 to inhibit bone formation. Nature medicine 19, 93-100.
21. Alam MM, O'Neill LA (2011) MicroRNAs and the resolution phase of inflammation in macrophages. Eur J Immunol 41, 2482-2485. 22. Bhogal RH, Curbishley SM, Weston CJ, Adams DH, Afford SC (2010) Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transplantation 16, 1303-1313.
22. Bhogal RH, Curbishley SM, Weston CJ, Adams DH, Afford SC (2010) Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transplantation 16, 1303-1313.
23. Tan S, Yokoyama Y, Wang Z, Zhou F, Nielsen V, et al. (1998) Hypoxia-reoxygenation is as damaging as ischemia-reperfusion in the rat liver. Critical care medicine 26, 1089-1095. (Pubitemid 28272862)
24. McGhan LJ, Jaroszewski DE (2012) The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation. Injury 43, 129-136.
25. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA (2008) Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 1471, 153-159. (Pubitemid 351626076)
26. Nace GW, Huang H, Klune JR, Eid RE, Rosborough BR, et al. (2013) Cellularspecific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice.Hepatology 58, 374-87.
27. Luan X, Liu Y, Li M (2012) The role of CD14 and Toll-like receptor 4 of Kupffer cells in hepatic ischemia-reperfusion injury in rats. Transplant Proc 44, 937-941.
28. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, et al. (2005) Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175, 7661-7668. (Pubitemid 41713466)
29. Taganov KD, Boldin MP, Baltimore D (2007) MicroRNAs and immunity: tiny players in a big field. Immunity 26, 133-137. (Pubitemid 46329443)
30. Ye Y, Perez-Polo JR, Qian J, Birnbaum Y (2011) The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics 43, 534-542.
31. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, et al. (2011) NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci USA 108, 9184-9189.
32. O'Neill LA, Sheedy FJ, McCoy CE (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nature Reviews Immunology 11, 163-175.
33. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of experimental medicine 208, 1189-1201.
34. van Golen RF, van Gulik TM, Heger M (2012) The sterile immune response during hepatic ischemia/reperfusion. Cytokine&Growth Factor Reviews 23, 69-84.
35. Schwabe RF, Brenner DA (2006) Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways[J]. American Journal of Physiology-Gastrointestinal and Liver Physiology 290, G583-G589.
36. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, et al. (2005) Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. The Journal of Immunology 174, 2037-2045. (Pubitemid 40223946)
37. Uhrig A, Banafsche R, Kremer M, Hegenbarth S, Hamann A, et al. (2005) Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. Journal of leukocyte biology 77, 626-633. (Pubitemid 40628742)
38. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K (2000) Endotoxin and cytokine regulation of toll-like receptor TLR 2 and TLR4 gene expression in murine liver and hepatocytes. Journal of Interferon & Cytokine Research 20, 915-921.
39. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, et al. (2009) Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20, 1744-1753.
40. Arias-Diaz J, Ildefonso JA, Munoz JJ, Zapata A, Jimenez E (2009) Both tacrolimus and sirolimus decrease Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion. Lab Invest 89, 433-445.
41. Lu L, Li G, Rao J, Pu L, Yu Y, et al. (2009) In vitro induced CD4+CD25+Foxp3+ Tregs attenuate hepatic ischemia-reperfusion injury. Int Immunopharmacol 9, 549-552.
42. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, et al. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914-929.
43. Zhang L, Chopp M, Liu X, Teng H, Tang T, et al. (2012) Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway. Arteriosclerosis thrombosis and vascular biology 32, 1856-1864.